The CB1 Blocker Rimonabant Impairs Smell Through a Separate Receptor in the Olfactory Bulb
Rimonabant impaired olfactory discrimination in mice through TRPV1 receptors in the olfactory bulb rather than through its known CB1 receptor blocking action, revealing an unexpected mechanism for this drug.
Quick Facts
What This Study Found
Rimonabant is best known as a CB1 cannabinoid receptor blocker, but it also interacts with other receptors. This study investigated its effects on smell, a function increasingly linked to the endocannabinoid system.
CB1 knockout mice showed impaired olfactory discrimination, confirming a role for CB1 in smell. But these mice also showed broader deficits in exploration, making interpretation difficult.
When rimonabant was given to normal mice, either systemically or directly into the olfactory bulb, it impaired olfactory discrimination. The surprise: this impairment was reversed by blocking TRPV1 receptors (using capsazepine), not by activating CB1 receptors. This means rimonabant's effect on smell works through TRPV1, not CB1.
Interestingly, only repeated (not single) doses of rimonabant impaired smell, and neither rimonabant nor the TRPV1 blocker affected general locomotion or exploration.
Key Numbers
CB1 knockout mice showed impaired olfactory discrimination. Short-term (but not acute) rimonabant impaired smell in wild-type mice. TRPV1 antagonist capsazepine reversed the olfactory deficit. Neither drug affected locomotion or general exploration in wild-type mice.
How They Did This
Mouse study using CB1 knockout mice and pharmacological approaches. Olfactory discrimination was tested using a habituation-dishabituation paradigm. Rimonabant and the TRPV1 antagonist capsazepine were administered systemically and directly into the olfactory bulb. Locomotion and exploratory behavior were also measured.
Why This Research Matters
This study reveals that a drug's effects can be mediated by receptors other than its primary target. For rimonabant specifically, TRPV1-mediated olfactory effects could have contributed to the altered eating behavior seen in clinical use, since smell and taste are closely linked to appetite.
The Bigger Picture
Olfaction is being explored as a biomarker for neurological and psychiatric conditions including schizophrenia and autism. Understanding how the endocannabinoid system and related receptors influence smell could have broader diagnostic and therapeutic implications.
What This Study Doesn't Tell Us
Mouse olfactory systems differ from humans. The TRPV1-mediated mechanism needs confirmation in other species. The study used a specific olfactory discrimination task that may not capture all aspects of olfactory function. CB1 knockout mice had broader behavioral deficits complicating interpretation.
Questions This Raises
- ?Did rimonabant's effects on smell contribute to its anti-obesity effects through appetite suppression?
- ?Could TRPV1 agonists or antagonists be used to modulate olfactory function in neuropsychiatric conditions?
Trust & Context
- Key Stat:
- Rimonabant impairs smell through TRPV1, not CB1 receptors
- Evidence Grade:
- Well-designed animal study with both genetic and pharmacological approaches, but limited to mice with uncertain translation to humans.
- Study Age:
- Published in 2016. The intersection of cannabinoid receptors, TRPV1, and sensory processing remains an active research area.
- Original Title:
- Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit.
- Published In:
- The Chinese journal of physiology, 59(1), 21-32 (2016)
- Authors:
- Hu, Sherry Shu-Jung(2)
- Database ID:
- RTHC-01180
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Does the endocannabinoid system affect smell?
Yes. CB1 knockout mice have impaired olfactory discrimination, and the CB1 blocker rimonabant also impairs smell, though through a different mechanism involving TRPV1 receptors.
Why does this matter beyond basic science?
Smell is closely linked to appetite and eating behavior, and olfactory changes are being explored as biomarkers for neuropsychiatric conditions. Understanding the cannabinoid-olfactory connection could have both diagnostic and therapeutic implications.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-01180APA
Hu, Sherry Shu-Jung. (2016). Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit.. The Chinese journal of physiology, 59(1), 21-32. https://doi.org/10.4077/CJP.2016.BAE366
MLA
Hu, Sherry Shu-Jung. "Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit.." The Chinese journal of physiology, 2016. https://doi.org/10.4077/CJP.2016.BAE366
RethinkTHC
RethinkTHC Research Database. "Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Ind..." RTHC-01180. Retrieved from https://rethinkthc.com/research/hu-2016-involvement-of-trpv1-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.